Highlights include:
- Real-life safety and efficacy of
autologous SCT in elderly MM - Lenalidomide maintenance
vs. observation for newly
diagnosed MM - Subclonal TP53 copy number is
associated with MM prognosis
Download here –Â Multiple Myeloma Research Review Issue 29